Atopic Dermatitis Market - Global Size, Share, Trends, Growth and Forecast Year ( 2023 – 2032 )
Atopic Dermatitis Definition
Atopic dermatitis, also known as eczema, is a chronic skin condition that causes itching, redness, and inflammation. The exact cause of atopic dermatitis is not known, but it is thought to be a combination of genetic and environmental factors.
A treatment algorithm for atopic dermatitis would typically start with the use of topical therapies, such as moisturizers and mild corticosteroids. If these are not effective, a healthcare provider may move on to more potent topical corticosteroids or add phototherapy. For patients with moderate-to-severe atopic dermatitis, systemic therapy with immunomodulators or biologics may be considered.
Atopic Dermatitis Market Share and Size
The market size for Atopic Dermatitis Market was USD 14.2 billion in the year 2022. It is expected that the market size for Atopic Dermatitis will increase by approximately USD 33.6 billion by 2032 as the market for Atopic Dermatitis is continuously growing at a compound annual growth rate (CAGR) of 9.0% during the forecast period 2023-2032.
|
Atopic Dermatitis Market Report Scope |
|
|
Base Year Market Size |
2022 USD 14.2 billion
|
|
Forecast Year Market Size
|
2032 USD 33.6 billion |
|
CAGR Value
|
9.0% from 2023 to 2032 |
|
Segmentation
|
|
|
Challenges
|
|
|
Growth Drivers
|
|
Atopic Dermatitis Market Key Drivers
There are various factors which help in the growth of the Atopic Dermatitis Market. They are as follows:
- Increasing prevalence of atopic dermatitis: The prevalence of the disease is rising, driving the market growth.
- Advancements in treatment options: The treatments are getting advanced and more effective, driving the market demand.
- Growing awareness of the disease: More diagnosis is taking place because of the increasing awareness among patients and healthcare providers, leading to market growth.
- Rising healthcare expenditure: People are spending more on health, driving the market growth for atopic dermatitis.
- Increased R&D investments: The pharmaceuticals are investing more in the research and development of new drugs, driving market growth.
- Growth in the geriatric population: The aging population is more prone to atopic disease, driving market growth.
Atopic Dermatitis Market Challenges
There are many challenges which are faced by Atopic Dermatitis Market. They are listed below:
- High cost of treatment: The cost of treatment is high, due to which all patients could not afford it, which creates a barrier to the market.
- Limited treatment options for some patients: The traditional treatment is unsuitable for some patients, which can be challenging.
- Stringent regulatory requirements: The regulations are strict, due to which it takes time to develop a new drug, which may pose a challenge for companies.
- Reimbursement issues: Some countries have reimbursement issues, and this can limit access to new treatment options.
- Safety concerns: Some drugs pose severe side-effect, which is a concern for patients and may pose a challenge for healthcare providers.
- Lack of understanding of the disease: Lack of understanding of the disease to the patient and the healthcare provider may pose a challenge to effective treatment.
Atopic Dermatitis Market Regional Synopsis
- North America: It is the largest market due to the high prevalence of the condition in the region. There is the availability of advanced treatment options. The United States is a major market.
- Europe: It is a significant market due to the high prevalence of the condition and advanced treatment options. The market is driven by key players.
- Asia Pacific: It has the highest growth rate due to increasing awareness of the disease. The market is driven by increasing disposable incomes and a growing geriatric population
- Rest of the World: Countries such as Latin America, the Middle East, and Africa are included in this region and are expected to grow moderately due to increasing awareness of the disease.
Atopic Dermatitis Market Segmentation
The Atopic Dermatitis Market is segmented into various categories which are listed below:
By drug class:
- Corticosteroids
- Calcineurin Inhibitors
- Immunomodulators
- Biologics
By distribution channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By geography:
- North America
- Europe
- Asia Pacific
- Rest of the World
Atopic Dermatitis Market Key Players
- Sanofi
- Novartis
- Pfizer
- GlaxoSmithKline
- AstraZeneca
- AbbVie
- Regeneron
- Mallinckrodt
- Others
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
- Publication date: 19th September 2023
- Base year: 2022
- Forecast year: 2023-2033
- Format: PDF, PPT,Word,Excel
- Quick Contact -
- ISO Certified Logo -
Frequently Asked Questions(FAQ)
Atopic Dermatitis Market
-: Our Clients :-
